Yinson Annual Report 2021

335 ANNUAL REPORT 2021 6. Where an authorised nominee appoints two (2) proxies, or where an exempt authorised nominee appoints two (2) or more proxies, the proportion of shareholdings to be represented by each proxy must be specified in the instrument appointing the proxies. 7. The instrument appointing a proxy shall be in writing signed by the appointor or his/ her attorney duly authorised in writing or, if the appointor is a corporation, either under its common seal or under the hand of an officer or attorney duly authorised. 8. The appointment of proxy may be made in a hardcopy form or by electronic means as follows: (i) Via hardcopy form The instrument appointing a proxy and the power of attorney or other authority, if any, under which it is signed or a notarially or certified copy of that power or authority shall be deposited at the Company’s Share Registrar, Securities Services (Holdings) Sdn. Bhd. at Level 7, Menara Milenium, Jalan Damanlela, Pusat Bandar Damansara, Damansara Heights, 50490 Kuala Lumpur, Malaysia, not less than forty-eight (48) hours before the time for holding the meeting or any adjournment thereof. (ii) Via online system The instrument appointing a proxy can be electronically submitted to the Share Registrar via Securities Services e-Portal at www.sshsb.net.my/login (Kindly refer to the ‘Administrative details’ section for the 28 th AGM for further information). 9. Pursuant to Paragraph 8.29A of Main Market Listing Requirements of Bursa Malaysia Securities Berhad, all resolutions set out in this notice will be put to vote on a poll. 10. Depositors who appear in the Record of Depositors as at 8 July 2021 shall be regarded as members of the Company who are entitled to attend the 28 th AGM or appoint proxies to attend, speak and vote on his/ her behalf. EXPLANATORY NOTES ON ORDINARY BUSINESS: 1. ITEM 1 OF THE AGENDA – RECEIPT OF REPORT AND AUDITED FINANCIAL STATEMENTS The Audited Financial Statements together with the reports of the Directors and Auditors in Agenda item no. 1 is meant for discussion only as the provision of Section 340(1)(a) of the Act, does not require a formal approval of shareholders. Hence, this item on the Agenda is not put forward for voting. 2. ORDINARY RESOLUTIONS 2 & 3 – DIRECTORS’ FEES AND BENEFITS In March 2021, the Nominating and Remuneration Committee (“NRC”) had reviewed the fees and benefits of the Board of Directors (“Board”) and Board Committees taking into consideration the market trends for similar positions, time commitment and responsibilities of the respective Directors. No revision of Directors’ fees and benefits have been recommended by the NRC and the structure of Directors’ fees and benefits remained as follows: Type of Fees RM Board fees Non-Executive Director/ Independent Director 200,000/annum Executive Director 50,000/annum Chairman of the Board 60,000/annum Audit Committee/ Board Risk Management Committee fees Committee Chairman fees 30,000/annum Committee Member fees 20,000/annum Other Board Committees Committee Chairman fees 20,000/annum Committee Member fees 10,000/annum NOTICE OF ANNUAL GENERAL MEETING